EWA
TXG icon

EverSource Wealth Advisors’s 10x Genomics TXG Stock Holding History

EverSource Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Sell
5,797
-1,389
-19% -$36.4K 0.01% 955
2026
Q1 		$153K Buy
7,186
+1,012
+16% +$20.2K ﹤0.01% 1198
2025
Q4 		$101K Sell
6,174
-13
-0.2% -$196 ﹤0.01% 1308
2025
Q3 		$72.3K Sell
6,187
-1,303
-17% -$17K ﹤0.01% 1446
2025
Q2 		$86.7K Buy
7,490
+5,025
+204% +$45.8K ﹤0.01% 1285
2025
Q1 		$21.5K Buy
2,465
+2,291
+1,317% +$28.9K ﹤0.01% 1651
2024
Q4 		$2.5K Sell
174
-64
-27% -$1.01K ﹤0.01% 2631
2024
Q3 		$5.37K Buy
238
+99
+71% +$2.05K ﹤0.01% 2198
2024
Q2 		$2.87K Buy
139
+12
+9% +$314 ﹤0.01% 2427
2024
Q1 		$3.72K Buy
127
+73
+135% +$3.21K ﹤0.01% 2177
2023
Q4 		$3.02K Buy
54
+50
+1,250% +$2.18K ﹤0.01% 2050
2023
Q3 		$165 Hold
4
– – ﹤0.01% 2447
2023
Q2 		$223 Buy
+4
New +$216 ﹤0.01% 2418
2022
Q4 		– Sell
-31
Closed -$1K – 2429
2022
Q3 		$1K Buy
+31
New +$1.18K ﹤0.01% 1905

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EverSource Wealth Advisors's TXG Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its 10x Genomics (TXG) stake by 19% in Q2 2026, selling an estimated $36.4K and leaving 5,797 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #955.

EverSource Wealth Advisors first reported a position in TXG in Q3 2022 and has held it in 14 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • EverSource Wealth Advisors held 5,797 shares of 10x Genomics worth $222K as of Q2 2026.
  • EverSource Wealth Advisors sold 1,389 10x Genomics shares in Q2 2026, an estimated $36.4K.
  • 10x Genomics made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #955 holding.
  • EverSource Wealth Advisors first reported a position in 10x Genomics in Q3 2022 and has held it in 14 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.